BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$140M |
| 2 |
iShares US Financials ETF
IYF
|
+$119M |
| 3 |
AGN
Allergan plc
AGN
|
+$100M |
| 4 |
Charter Communications
CHTR
|
+$95.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$82.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$909M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.85% |
| 2 | Financials | 5.5% |
| 3 | Healthcare | 5.05% |
| 4 | Consumer Discretionary | 4.67% |
| 5 | Industrials | 3.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Enerpac Tool Group
EPAC
$1.88B
| $538K | ﹤0.01% |
20,682
+9,859
| +91% | +$241K |
|
2302
CALL
Simon Property Group
SPG
$71.2B
| $536K | ﹤0.01% |
36
+8
| +29% | +$1.2K |
|
2303
Employers Holdings
EIG
$869M
| $536K | ﹤0.01% |
12,834
+6,083
| +90% | +$258K |
|
|
COLO
2304
Global X MSCI Colombia ETF
COLO
$216M
| $535K | ﹤0.01% |
13,572
-2,488
| -15% | -$93K |
|
2305
Sprouts Farmers Market
SFM
$7.71B
| $533K | ﹤0.01% |
27,537
-9,548
| -26% | -$185K |
|
2306
Cal-Maine
CALM
$3.83B
| $532K | ﹤0.01% |
12,448
+6,132
| +97% | +$255K |
|
|
IMMU
2307
DELISTED
Immunomedics Inc
IMMU
| $530K | ﹤0.01% |
25,032
-6,038
| -19% | -$107K |
|
2308
Safety Insurance
SAFT
$1.52B
| $529K | ﹤0.01% |
5,714
+2,993
| +110% | +$292K |
|
2309
Trade Desk
TTD
$6.72B
| $527K | ﹤0.01% |
20,280
-45,560
| -69% | -$1.03M |
|
2310
CALL
PVH
PVH
$3.77B
| $526K | ﹤0.01% |
50
| – | – |
|
2311
Capitol Federal Financial
CFFN
$1.09B
| $524K | ﹤0.01% |
38,181
+12,256
| +47% | +$173K |
|
|
CTRA
2312
CALL
DELISTED
Coterra Energy
CTRA
| $524K | ﹤0.01% |
301
| – | – |
|
|
MRTX
2313
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $523K | ﹤0.01% |
4,061
-863
| -18% | -$83.2K |
|
|
CEQP
2314
DELISTED
Crestwood Equity Partners LP
CEQP
| $523K | ﹤0.01% |
16,973
+1,490
| +10% | +$49.1K |
|
2315
Enpro
NPO
$7.21B
| $523K | ﹤0.01% |
7,819
+4,072
| +109% | +$271K |
|
2316
Kinsale Capital Group
KNSL
$8.59B
| $523K | ﹤0.01% |
5,142
+1,706
| +50% | +$170K |
|
2317
Dine Brands
DIN
$434M
| $521K | ﹤0.01% |
6,241
+1,647
| +36% | +$128K |
|
2318
Comfort Systems
FIX
$62.4B
| $520K | ﹤0.01% |
10,428
+3,536
| +51% | +$172K |
|
2319
Chemours
CC
$2.4B
| $519K | ﹤0.01% |
28,710
-8,719
| -23% | -$145K |
|
2320
Otter Tail
OTTR
$3.9B
| $519K | ﹤0.01% |
10,111
+2,892
| +40% | +$150K |
|
2321
Warrior Met Coal
HCC
$5.17B
| $518K | ﹤0.01% |
24,508
+1,272
| +5% | +$26K |
|
2322
Atkore
ATKR
$3.17B
| $517K | ﹤0.01% |
12,780
+1,086
| +9% | +$40.2K |
|
2323
Atlantic Union Bankshares
AUB
$6.14B
| $517K | ﹤0.01% |
13,758
-1,056
| -7% | -$39.8K |
|
|
DEA
2324
Easterly Government Properties
DEA
$1.18B
| $516K | ﹤0.01% |
8,692
+3,892
| +81% | +$220K |
|
2325
Fossil Group
FOSL
$324M
| $515K | ﹤0.01% |
65,376
+50,110
| +328% | +$462K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2019 Portfolio in Review
As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.9% of assets, down from 8.4% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.
- BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
- BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
- BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
- BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
- BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.